\
&
Contact us
Published on | 3 years ago
ProgrammesThe results of the evaluation are:
Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs - HORIZON-HLTH-2022-DISEASE-06-02-two-stage
Vaccines 2.0 - developing the next generation of vaccines - HORIZON-HLTH-2022-DISEASE-06-03-two-stage
Development of new effective therapies for rare diseases - HORIZON-HLTH-2022-DISEASE-06-04-two-stage
In accordance with General Annex D of the Work Programme, the evaluation of the first-stage proposals was made looking only at the criteria 'excellence' and 'impact'. The threshold for both individual criteria is 4. The overall threshold applying to the sum of the two individual scores was set at a level that ensures the total requested budget of proposals admitted to stage 2 is as close as possible to three times the available budget, and not less than two and a half times the available budget, and is as follows:
Source: Funding & Tenders Portal (Funding Updates)
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Marie Skłodowska-Curie Action (MSCA) European Innovative Training Network “PBNv2 - Next generation Pass-By Noise approaches for new powertrain vehicles” started in May 2017. Their research has the shared objective of investigating the possibilities to decrease pass-by noise of vehicles.
The project is a collaboration between 17 research institutions and companies in the European automotive R&D and provides a learning environment for 14 PhD fellows. The Belgian partner is the Noise and Vibration Research Group of KU Leuven, and this project is one of the many Horizon 2020 MSCA Innovative Training Networks that the KU Leuven research group participates in.